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Abstract: 25 
CD59 is a membrane-bound regulatory protein that inhibits the assembly of the terminal 26 
membrane attack complex (C5b-9; MAC) of complement.  From its original discovery in 27 
humans almost thirty years ago, CD59 has been characterized in a variety of species, from 28 
primates to early vertebrates such as teleost fish.  CD59 is ubiquitous in mammals; however, we 29 
have described circumstantial evidence suggesting that guinea pigs (Cavia porcellus) lack CD59, 30 
at least on erythrocytes. Here, we have used a combination of phylogenetic analyses with 31 
syntenic alignment of mammalian CD59 genes to identify the only span of genomic DNA in 32 
Cavia porcellus that is homologous to a portion of mammalian CD59, and show that this 33 
segment of DNA is not transcribed.  We describe a pseudogene sharing homology to exons 2 34 
through 5 of human CD59 present in the Cavia porcellus genome.  This pseudogene was flanked 35 
by Cavia porcellus homologs of two genes, FBXO3 and ORF91, a relationship and orientation 36 
that was consistent with other known mammalian CD59 genes.  Analysis using RNA-Seq 37 
confirmed that this segment of chromosomal DNA was not transcribed.  We conclude that 38 
guinea pigs lack an intact gene encoding CD59, the first report of a mammalian species that does 39 
not express a functional CD59. The pseudogene we describe is likely the product of a genomic 40 
deletion event during its evolutionary divergence from other members of the rodent order.    41 
 42 
 43 
 44 
 45 
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Introduction: 48 
The complement system plays an essential role in innate and adaptive immunity in all known 49 
vertebrate animals (1, 2).  Complement immunity is initiated through antigen-antibody 50 
interactions (i.e. the classical pathway) (3), the activation and amplification of C3 in the presence 51 
of activating surfaces (i.e. alternative pathway or amplification loop) (4), or the recognition of 52 
sugar-moieties (i.e. lectin pathway) (5), all ultimately leading to the cleavage and activation of 53 
C3 (6).  This in turn, initiates the formation of the membrane attack complex (MAC), composed 54 
of components C5b-C9 (7).  Once formed, the MAC causes perforation and lysis of target cell 55 
membranes.  56 
In vertebrates, complement regulators (CReg) have been well-characterized (8).  CReg are 57 
soluble or membrane-bound proteins that are responsible for the protection of host cells from 58 
complement-mediated damage (9, 10).  One of the most ubiquitously expressed CReg is CD59, 59 
an 18-20 kDa glycosylphosphatidylinositol (GPI)-anchored membrane-bound protein, expressed 60 
on almost all cell types in mammals, and preventing MAC assembly by inhibition of the 61 
interaction of the C5b-8 complex with C9 (11).  While initially characterized in humans, CD59 62 
has since been identified across vertebrate species, including mammals, birds, reptiles, 63 
amphibians, and boned fish (8, 12-14).  Structural conservation of this molecule across animal 64 
phyla, as well is its expression across all types, suggest a high degree of importance of CD59 in 65 
protecting the host from complement-mediated damage.     66 
Early work using recombinantly expressed or native human CD59 suggested that the MAC 67 
inhibitory activity was species specific (15, 16).  However, subsequent work comparing the 68 
activities of human, rat, pig and sheep CD59 analogs against different species sources of 69 
complement found a high degree of cross-species activity (17).  Notable in this latter study was 70 
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that guinea pig erythrocytes were uniquely sensitive to MAC-induced lysis regardless of the 71 
species source of the MAC proteins, including homologous MAC proteins, and were uniquely 72 
protected from complement-mediated lysis by exogenously added CD59 from the various 73 
species. These observations provoked the suggestion that guinea pig erythrocytes lacked an 74 
endogenous CD59 analog (17).  75 
Although this unique susceptibility of guinea pig erythrocytes to complement-mediated 76 
hemolysis has been known for several decades, there is still no definitive explanation as to why 77 
this is the case. Components of the guinea pig complement system have been purified and 78 
characterized from as early as the 1960´s (18, 19), with all components of the activation 79 
pathways and terminal pathway characterized (20, 21).  Guinea pig complement efficiently lyses 80 
“classical” targets such as antibody-sensitised sheep erythrocytes, demonstrating that there is not 81 
an underlying complement deficiency. Other CReg, including decay accelerating factor (DAF; 82 
CD55) and membrane cofactor protein (MCF; CD46) have been identified in and cloned from 83 
guinea pig (22, 23) , but CD59 remains unidentified and an enigma.    84 
Here we describe a combined immunochemical, phylogenetic and genomic approach to 85 
elucidate whether guinea pigs express CD59. Our data further strengthen the contention that 86 
guinea pigs do not express CD59. We show that the gene encoding for CD59 in the Cavia 87 
porcellus genome has become a pseudogene. Together, the data demonstrate that there is no 88 
functional gene encoding CD59 in guinea pigs; these findings provide an explanation for the 89 
unique hemolytic properties attributed to guinea pig erythrocytes.     90 
 91 
  92 
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Materials and Methods:  93 
Expression of CD59 on guinea pig erythrocytes 94 
The expression of CD59 on guinea pig erythrocytes was assessed using six different antibodies; 95 
two rabbit polyclonal antibodies generated against mouse CD59a and known to be cross-reactive 96 
across species, including human CD59, and two monoclonal antibodies specific for human CD59 97 
and mouse CD59a respectively. Erythrocytes from normal mice (C57/Bl), CD59a-deficient mice 98 
and human were used as positive and negative controls. Erythrocytes from each source were 99 
washed three times in isotonic phosphate-buffered saline (PBS) with centrifugation at 2000 g for 100 
10 minutes to pellet after each wash, then resuspended to 0.1% (v/v) in ﬂow cytometry buffer 101 
(FCB; PBS pH 7.4 supplemented with 1% bovine serum albumin (w/v),). Aliquots (100µl) were 102 
incubated with 1µg of the appropriate anti-CD59 antibody at 4°C for one hour, washed twice in 103 
FCB then incubated for one hour at 4°C with the appropriate ﬂuorescein (FITC)-conjugated 104 
secondary; donkey anti-mouse IgG (Jackson Immunoresearch, 715-096-151), goat anti-rabbit 105 
IgG (Oxford Biotechnology L320-NC51Z), or rabbit anti-rat IgG (Sigma, F-1763) at the 106 
recommended dilution in FCB. Stained erythrocytes were washed as above and analysed by flow 107 
cytometery using a Becton Dickinson FACScalibur. Erythrocytes from each species yielded a 108 
single population when analysed for forward and side scattered and for each, the entire 109 
population was gated for analysis of fluorescent staining.  110 
 111 
Gene Alignments 112 
Human CD59 gene (Ensembl transcript ID ENST00000351554.7) localized to Chromosome 11 113 
(bases 33,708,865-33,736,445, translated from the negative strand) was used as the basis for 114 
syntenic and codon-based alignments.  The five exons from this region were used for alignment 115 
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with the Cavia porcellus genome from the Ensembl annotation of the Broad Institute’s CavPor3 116 
assembly, version 90 (24).   117 
 118 
Syntenic Alignments 119 
As the human CD59 gene and other mammalian CD59 genes are flanked by genes FBXO3 and 120 
C11orf91, alignments were performed to a chromosomal region of the Cavia porcellus genome 121 
flanked by their respective gene homologs.  This region, characterized by Ensembl as Scaffold 122 
DS562947.1 (bases 5,004,217 to 5,025,988), was used for alignment using individual human 123 
CD59 exons.   124 
 125 
Exon Alignments 126 
All five exons of human CD59 (Ensembl accession numbers ENSE00001326619, 127 
ENSE00001364419, ENSE00000824399, ENSE00000710249, ENSE00002187503, 128 
respectively) were aligned with the Ensembl annotated CavPor3 genome assembly, focusing on 129 
Scaffold DS562947.1 as described in the previous section.  Each alignment was performed using 130 
the default parameters of the genomic alignment, changing only the default start/stop sequences 131 
in order to match the precise beginning and end of each exon (as indicated in Table I).  Sequence 132 
similarity was calculated using the ClustalW aligned sequences and the PRABI suite of the Pole 133 
Bioinformatique Lyonnais website (https://prabi.ibcp.fr) (25).   134 
 135 
Phylogenetic Analysis 136 
In order to determine the evolutionary relationship of the Cavia porcellus CD59 pseudogene 137 
with other vertebrate CD59 genes, a phylogenetic tree was constructed using the putative cDNA 138 
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encoding CD59 from 43 species (listed in Supplementary Table I).  All cDNA sequences were 139 
aligned using ClustalW, and the phylogenetic tree generated using the Neighbor-Joining method 140 
in the MEGA6 program suite (26), with bootstrap values n=1000.     141 
Another phylogenetic tree was constructed, based on the taxonomic organization of each of the 142 
species described in Supplementary Table I.  In this case, the taxonomic tree was generated using 143 
the PhyloT (http://phylot.biobyte.de) web-based phylogenetic tree generator (27), and the 144 
taxonomic NCBI identifiers for each species.     145 
 146 
RNA-Seq Analysis 147 
To determine whether any transcriptional products were derived from the identified CD59 148 
pseudogene, alignments were performed using RNA-Seq data, acquired from the Broad 149 
Institute’s CavPor 3 assembly (Genbank assembly no. GCF_000151735.1).  The reads were 150 
analyzed using NCBI’s Genome Data Viewer, using the default aggregate settings of the Cavia 151 
porcellus annotation release 102.  This setting included reads from brain, liver, lung, skeletal 152 
muscle, kidney and cervix; tracks displaying RNA-Seq exon coverage were used as a measure of 153 
expression, compared with other previously characterized guinea pig complement regulators 154 
CD46, CD55 and Crrp (complement receptor-related protein, Crry homolog).   155 
 156 
  157 
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Results: 158 
Flow cytometeric analysis of CD59 expression in erythrocytes. 159 
Erythrocytes from guinea pig, normal mouse, CD59a-deficient mouse and human were stained 160 
with monoclonal and polyclonal antibodies against mouse CD59a or human CD59. Human 161 
erythrocytes were strongly positive with the monoclonal anti-human CD59 MEM43, and 162 
moderately strongly with two different polyclonal antibodies raised against mouse CD59a 163 
(Figure 1; plate III); mouse erythrocytes stained positively with the rat monoclonal anti-mouse 164 
CD59a and with the two polyclonal anti-CD59a antibodies (Figure 1; plate IV); CD59a-deficient 165 
mouse erythrocytes used here as a specificity control were negative for all antibodies tested 166 
(Figure 1; plate II). Guinea pig erythrocytes were also negative for all antibodies tested (Figure 167 
1; plate I). 168 
 169 
Syntenic alignment of human CD59 exons with Cavia porcellus 170 
Initial attempts to identify guinea pig CD59 cDNA utilised BLAST searches against the Cavia 171 
porcellus genome, using default parameters derived from mammalian CD59 cDNAs and amino 172 
acid sequences. The only homologies identified were members of the Ly6 protein family, 173 
leukocyte surface protein lacking the conserved residues and motifs that characterise vertebrate 174 
CD59 (28, 29). 175 
The second strategy to locate a putative CD59 gene in the Cavia porcellus genome involved 176 
syntenic alignment with the region of human chromosome 11 encoding the CD59 gene.  The 177 
CD59 gene is located between the FBXO3 and C11orf91 genes in multiple mammalian genomes. 178 
Individual human CD59 exons were aligned on a chromosomal scaffold of Cavia porcellus, 179 
limited to a region between the FBXO3 and C11orf91 homologs.  The results are shown in Table 180 
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I. No DNA sequence homologous with human CD59 exon 1 was found, but homologs of human 181 
CD59 exons 2-5 were located within the 27.3 kb region, annotated by Ensembl as Scaffold 182 
DS562947.1in the Cavia porcellus genome.  Individual alignments of human exon 2, 3 and 4 183 
showed nucleotide identities of 55.8%, 62.3% and 57.8%, respectively.  The homolog of human 184 
exon 5 showed only 25.8% identity, primarily because the exon 5 homolog was truncated 185 
compared to its human counterpart.  A schematic diagram of this alignment is shown in Figure 2.      186 
  187 
Alignment of human CD59 ORF-encoding exons with Cavia porcellus homologs. 188 
In order to determine the degree of conservation at the protein level between human CD59 and a 189 
potential product of the identified guinea pig exon homologs, nucleotide alignments were 190 
performed between the open reading frame (ORF)-encoding regions of human CD59 (exons 3, 4 191 
and 5) and the exon homologs identified in the Cavia porcellus genome.  As seen in Figure 3, the 192 
protein product of human exon 3, encoding the majority of the N-terminal leader peptide, shared 193 
a high degree of amino acid identity and similarity to the predicted product of the Cavia 194 
porcellus homolog, without any frameshifts (i.e. the sequence translated in a +1 ORF).  In 195 
particular, the leucine-rich motifs, phenylalanine and cysteine residues were conserved in the 196 
predicted Cavia porcellus CD59 leader sequence.  197 
Conservation at the (predicted) protein level was also observed when aligning human CD59 exon 198 
4 and its Cavia porcellus counterpart without any frameshift (i.e. +1 ORF).  In the human 199 
sequence, exon 4 encodes the last three amino acids of the leader peptide and the first 30 amino 200 
acids of the mature protein (starting LQCY); these 30 amino acids include five cysteine residues 201 
essential for protein stability, four of which are conserved in the predicted Cavia porcellus 202 
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sequence. The first cysteine residue is displaced into the predicted leader sequence in the guinea 203 
pig.   204 
Divergence between the two genomes were most pronounced when comparing the protein 205 
product of human CD59 exon 5 with the predicted Cavia porcellus exon 5 product. There was 206 
some sequence conservation through the first 24 amino acids (residues 31 to 54 in the mature 207 
human protein) with conservation of the two cysteine residues in this segment but not the 208 
tryptophan residue (W40 in mature human CD59) known to be a key functional residue in 209 
multiple species CD59 analogs; indeed, in the selected ORF this (W40 in human) codon is 210 
replaced by a stop codon.  211 
Taken together, these results demonstrate that the genomic sequence identified as the sole 212 
homolog of CD59 in the Cavia porcellus genome is a pseudogene incapable of producing a 213 
functional CD59 protein.   214 
 215 
Phylogenetic and comparative analysis of Cavia porcellus CD59 pseudogene with other 216 
vertebrate CD59 cDNAs  217 
In order to determine whether the identified Cavia porcellus CD59 pseudogene shares a 218 
phylogenetic relationship with other vertebrate CD59 homologs, a phylogenetic tree was 219 
generated from CD59 cDNA sequences from diverse species (Figure 4; SupplementaryTable I), 220 
using a Neighbor-Joining method with bootstrap confidence intervals of n-=1000.  These results 221 
were compared to a pruned phylogenetic tree, based on NCBI taxonomy (not shown); the trees 222 
displayed a high degree of similarity between clades, with CD59 conservation distributed along 223 
phylogenetic classes (i.e. more similar CD59 sequences clustering along avian, reptilian, fish and 224 
mammalian orders).  Furthermore, within mammals, CD59 clusters were distributed consistently 225 
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along taxonomical order (i.e. rodents, primates and carnivores).  Based on these results, a 226 
pairwise alignment was performed using the available cDNA sequence from the naked mole rat 227 
(Heterocephalus glaber), the species most closely related to Cavia porcellus in the analysis.   228 
 229 
Pairwise nucleotide alignment of Cavia porcellus CD59 pseudogene and Heterocephalus glaber 230 
CD59 cDNA 231 
A pairwise alignment between the Cavia porcellus CD59 pseudogene and the protein-encoding 232 
CD59 cDNA of its most taxonomically related species, the naked mole rat demonstrated a high-233 
degree of conservation throughout the sequence, although a 15-bp gap and two 3-bp gaps were 234 
observed in the Cavia porcellus CD59 pseudogene, all consistent with keeping the sequence in-235 
frame.  236 
 237 
RNA-Seq Analysis of Cavia porcellus CD59 Pseudogene Transcription.   238 
In order to test whether the Cavia porcellus CD59 pseudogene was transcribed, the predicted 239 
sequences from all 4 characterized “exon” domains were aligned with RNA-Seq data acquired 240 
from Genbank, based on the Broad Institute’s CavPor3 assembly; and included reads from brain, 241 
liver, lung, skeletal muscle, kidney and cervix.  Expression was visualized using the NCBI 242 
Genome Browser.  This analysis was also performed with other known Cavia porcellus 243 
complement regulators, CD46, CD55 and Crrp.  As seen in Figure 6, the three characterized 244 
complement regulators had significant RNA expression throughout the gene, with signal 245 
intensities reaching nearly 17000 for CD59, 530 for CD46 and 300 for Crrp.  For each of the 246 
CD59 pseudogene “exons”, there was essentially no signal for expression, except for a weakly 247 
defined 80 bp region (corresponding to Ensembl scaffold DS562947.1: 5065147-5065227), 248 
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reaching a signal intensity of ~10; this segment corresponds to an intronic area between the 249 
regions homologous to exons 4 and 5 of human CD59.   250 
 251 
 252 
  253 
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Discussion: 254 
The propensity for guinea pig erythrocytes to be lysed by a variety of different animal sera, and 255 
to be effectively protected from lysis by incorporation of CD59 from other species led us to 256 
propose that guinea pig erythrocytes lacked a functional CD59 protein rendering them 257 
susceptible to lysis by homologous or heterologous complement (17). Although we had no data 258 
on other tissues and cell types we further speculated that guinea pigs might have a genetic lack of 259 
CD59, an anomaly given the wide species distribution of CD59 analogs.  260 
Here we set out to address this anomaly and provide evidence of the fate of CD59. First, we 261 
stained guinea pig erythrocytes with a panel of anti-mouse CD59a and anti-human CD59 262 
antibodies, including two polyclonal antibodies raised against mouse CD59a that showed broad 263 
species cross-reactivity, staining both mouse and human erythrocytes; specificity was 264 
demonstrated by showing that CD59a-deficient mouse erythrocytes were negative for all 265 
antibodies. Guinea pig erythrocytes showed no staining, supporting the contention that they 266 
lacked a CD59 analog.  267 
We then conducted an extensive genomic study using an annotated Cavia porcellus genome.  268 
BLAST alignments using other mammalian CD59 genes identified only limited homology to 269 
genes of the Ly6 superfamily of molecules; no gene possessing the conserved domains of CD59 270 
was found in the Cavia porcellus genome (28, 29). Syntenic alignments were then performed, 271 
looking for the Cavia porcellus genomic region corresponding to the region of human 272 
chromosome 11 containing the CD59 gene.  In mammalian species, the CD59 gene is flanked by 273 
the FBXO3 and C11orf91 genes; the Cavia porcellus FBXO3 and C11orf91 homologs were 274 
identified; however, no intact CD59 gene was located between these two genes. Individual 275 
alignments of the five human CD59 exons across this region identified regions of homology with 276 
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exons 2-5, exons 2-4 sharing a high degree of sequence similarity between human and guinea pig 277 
with putative in-frame ORFs.  In contrast, alignments with human exon 5, which codes for the 278 
majority of the mature protein sequence, identified putative regions of homology comprised of 279 
two adjacent, truncated regions (together, approximately 60% the size of its human counterpart) 280 
that did not contain a complete ORF but contained both non-sense mutations and deletions.  In 281 
humans, this region encodes for a Cysteine-Asparagine combination that appears to be highly 282 
conserved across vertebrate Ly6 family proteins (30).   The loss of this highly conserved region 283 
and the presence of nonsense and deletion mutations support the assertion that this segment of 284 
chromosomal DNA is no longer under functional constraint, but instead represents an inactive 285 
pseudogene prone to genetic drift.   286 
RNA-Seq analysis confirmed that no portion of any of the CD59 exon homologs were 287 
transcribed. Therefore, from an evolutionary perspective, it is likely that elements associated 288 
with the promoter have been lost.  The loss of this region, along with the loss of a human exon 1-289 
homologous region would suggest that a deletion event at the 5’-end of the gene may have 290 
contributed to the inactivation of a previously functional gene.  In contrast, expression of other 291 
Cavia porcellus CReg proteins was readily detectable from RNA-Seq, thereby indicating that 292 
other complement regulators were still functional, and that these components are likely sufficient 293 
to prevent MAC-associated autoimmune damage.   294 
The absence of a region homologous to exon 1 of human CD59 in the guinea pig genome may 295 
imply either high genetic drift, eliminating any significant similarity to human CD59 exon 1, or a 296 
deletion event removing the exon 1-like region.  The second possibility is of particular interest, 297 
since it may imply an ancestral region prone to genetic recombination.  This might help explain 298 
gene duplication events associated with the CD59 gene; CD59 gene duplication has been 299 
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described in mice (31), and a putative CD59 gene duplication event is reported in Chinese 300 
softshell turtle (Ensembl access number ENSPSIG00000007164).  In both cases, the gene 301 
duplication products are adjacent to each other, while still being syntenic to the FBXO3 gene.  In 302 
the mouse, the two CD59 genes are differentially expressed with CD59a broadly distributed in 303 
all tissues and CD59b expressed only in male genital tissue (31). The CD59 gene duplication 304 
product in Chinese softshell turtle lacks the conserved regions associated with a functional 305 
CD59.  Nevertheless, these two instances of gene duplication, combined with the putative gene 306 
deletion event in guinea pigs suggests a dynamic genetic element which may exist in CD59 307 
genes across all vertebrates. 308 
The fact that intact and functional CD59 genes have been found in all other available mammalian 309 
genomes suggests that loss of CD59 expression was caused by a mutation unique to guinea pigs 310 
(or an ancestral species).  From an evolutionary standpoint, the lack of a functional CD59 in 311 
guinea pigs adds to the debate on the importance of this molecule in protecting vertebrates from 312 
autoimmune damage.  CD59 is reported to be ubiquitously expressed on (almost) all cells of 313 
mammals (32) and is considered to be indispensable for immune homeostasis.  Studies using 314 
CD59a-knockout mice demonstrate that CD59 deficiency is compatible with life; the mice 315 
showed increased erythrocyte turnover and a compensated anemia, and increased pathology in a 316 
number of complement-mediated disease models (33-36).  CD59 deficiency in humans has 317 
serious consequences; isolated CD59 deficiency in humans was first described over 25 years ago 318 
in a Japanese patient presenting in his 20s with symptoms resembling paroxysmal nocturnal 319 
hemoglobinuria (37). More recently, CD59 deficiency was reported in several families of North 320 
African Jewish ethnicity, all cases presenting in infancy with chronic hemolysis and episodes of 321 
peripheral neuropathy resembling Guillain-Barre syndrome (38). All cases were homozygous for 322 
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a missense mutation in the CD59 gene, pCys89Tyr, and had no detectable CD59 on cell surfaces. 323 
Disease course was severe with high mortality. Other cases with remarkably similar clinical 324 
features but different CD59 mutations were subsequently described (39,40); importantly, 325 
treatment with the anti-C5 antibody eculizumab markedly improved both hemolytic and 326 
neurological symptoms.    327 
The relatively mild phenotype in CD59a knockout mice has been ascribed to the presence in 328 
rodents of another widely expressed complement regulator, Crry; this was shown to be essential 329 
for murine erythrocyte protection from complement attack, while CD59 was dispensable (41).  330 
To date, no Crry homolog has been reported in guinea pigs, although a truncated, homologous 331 
protein, Crrp has been described (42). The gene encoding for Crrp aligns with murine Crry and 332 
may serve a similar function, reducing the impact of the absence of CD59 in guinea pigs.  333 
Overall, the redundancy of membrane-bound complement regulators in rodents likely 334 
compensates for the lack of functional CD59 in guinea pigs.  Nevertheless, from an evolutionary 335 
perspective, the results presented in this analysis represent the first example of a species in which 336 
the CD59 gene has become a pseudogene, and demonstrates the capacity of a rodent species to 337 
regulate complement activation on self-cells independent of this molecule. 338 
 339 
 340 
  341 
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Figure Legends: 477 
Figure 1. Flow cytometric analysis of CD59 expression on erythrocytes. 478 
Guinea pig (I), CD59 deficient mouse (-CD59) (II), human (III) and wild-type mouse (+CD59) 479 
(IV) erythrocytes were stained with monoclonal anti-human CD59 MEM43 (E), monoclonal rat 480 
anti-mouse CD59a (F) or two different polyclonal anti-CD59a (G = anti CD59a.1, H = anti 481 
CD59a.2) followed by appropriate ﬂuorescein FITC-labelled secondary antibodies, then analyses 482 
by flow cytometry. Controls are: A = unstained cells, B = donkey anti-Mouse IgG, C = rabbit 483 
anti-rat IgG, D = goat anti-Rabbit IgG; all are overlapping and negative on each of the 484 
histograms.). Positive staining for CD59 was observed on human erythrocytes and on wild-type 485 
mouse erythrocytes (F, G, H) with the species-specific monoclonal and the two polyclonal 486 
antibodies (E, G, H). In contrast, guinea pig erythrocytes and erythrocytes from CD59a-deficient 487 
mice were negative for all antibodies tested.   488 
 489 
Figure 2.  Alignment of human CD59 exons to the Cavia porcellus genome.   490 
Nucleotide alignments from the human CD59 gene were compared to a sequenced scaffold 491 
annotated from the Ensembl guinea pig browser using the Broad Institute’s CavPor3 genome 492 
assembly (see Materials and Methods).  The precise degree of homology between segments is 493 
described in Table 1.   494 
 495 
Figure 3. Nucleotide alignments of the protein-encoding regions of human CD59.  496 
Exons 3, 4 and 5 of human CD59 were compared to homologous chromosomal regions of the 497 
Cavia porcellus genome.  It should be noted that the codon encoding the terminal glycine in 498 
exon 3 is composed of the two terminal nucleotides of exon 3, followed by the first nucleotide of 499 
25 
 
 
exon 4.  For all exons, the nucleotide sequences were translated into a +1 ORF. Identity (*) or 500 
similarity (. or :) between individual amino acid residues is indicated.     501 
 502 
Figure 4. CD59 phylogenetic tree based on NCBI taxonomic classification.  503 
CD59 coding regions of 44 vertebrate species were compared.  The taxonomy ID numbers are 504 
indicated in supplemental Table 1.  The CD59 phylogenetic tree was generated using a neighbor-505 
joining method, with bootstrap values from n=1000 indicated.  The box indicates that the species 506 
most phylogenetically related to guinea pig is the naked mole-rat. 507 
  508 
Figure 5. Nucleotide alignment of the CD59 ORF in naked mole rat and the putative Cavia 509 
porcellus CD59 pseudogene.   510 
The nucleotide sequences and derived amino acid sequences for naked mole rat (top) and guinea 511 
pig (bottom) CD59 are shown. Identity (*) or similarity (. or :) between individual amino acid 512 
residues is shown. 513 
   514 
Figure 6. RNA Seq profiles of guinea pig complement regulator genes.   515 
The location of the Cavia porcellus homologs of CD46, CD55 and Crrp were identified in the 516 
Ensembl annotation of the Broad Institute’s CavPor3 assembly; and RNA-Seq profiles for these 517 
and the genomic area corresponding to the Cavia porcellus CD59 pseudogene were obtained 518 
using NCBI Genome Browser viewer.  The location of each gene is as follows:  CD46- 519 
scaffold_DS562867.1: 15,332,888-15,365,235; CD55- scaffold_DS562867.1: 15,598,604-520 
15,622,439; Crrp- scaffold_DS562867.1: 15,425,329-15,451,739; CD59 pseudogene-scaffold_ 521 
DS562947.1:5,042,265-5,069,597.  Signal intensities are indicated in the diagram.      522 
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Supplemental Table I- Identification Of Different Animal CD59 cDNAs Used In This Study 523 
Taxonomic relationships between species are presented in Figure 4, where a rooted taxonomic tree was generated 524 
and comparted to a phylogenetic tree based on their respective CD59 cDNAs (see Materials and Methods).  All 525 
CD59 sequences were obtained from Ensembl, with the exception of the Large Yellow Croaker, Rainbow Trout and 526 
Common Name Species Name NCBI ID CD59 Acc No.  
Alpaca Vicugna pacos 30538 ENSVPAT00000007804.1 
Bushbaby Otolemur garnettii 30611 ENSOGAT00000003326.1 
Cat  Felis catus 9685 ENSFCAT00000010141.2 
Chicken Gallus gallus 9031 ENSGALT00000054780.1 
Chimpanzee Pan troglodytes 9598 ENSPTRT00000006570.4 
Chinese Softshell Turtle Pelodiscus sinensis 13735 ENSPSIT00000007520.1 
Cow Bos taurus 9913 ENSBTAT00000002967.2 
Dog  Canis lupus familiaris 9615 ENSCAFT00000044159.1 
Dolphin Tursiops truncatus 9739 ENSTTRT00000016371.1 
Duck Anas platyrhynchos 8839 ENSAPLT00000006990.1 
Ferret Mustela putorius furo 9669 ENSMPUT00000011623.1 
Flycatcher Ficedula albicollis 59894 ENSFALT00000001389.1 
Gibbon Nomascus leucogenys 61853 ENSNLET00000032353.1 
Gorilla Gorilla gorilla gorilla 9595 ENSGGOT00000016902.2 
Guinea Pig Cavia porcellus 10141 Not Available 
Hedgehog Erinaceus europaeus 9365 ENSEEUT00000014945.1 
Human Homo sapiens 9606 ENST00000351554.7 
Hyrax Procavia capensis 9813 ENSPCAT00000000528.1 
Kangaroo Rat Dipodomys ordii 10020 ENSDORT00000008867.1 
Large Yellow Croaker Larimichthys crocea 215358 DQ649025.1 
Macaque Macaca mulatta 9544 ENSMMUT00000070699.1 
Marmoset Callithrix jacchus 9483 ENSCJAT00000020355.1 
Megabat Pteropus vampyrus 132908 ENSPVAG00000008531.1 
Microbat Myotis lucifugus 59463 ENSMLUT00000013129.2 
Mouse (a) Mus musculus 10090 ENSMUST00000168176.7 
Mouse (b) Mus musculus 10090 ENSMUST00000090429.7 
Mouse Lemur Microcebus murinus 30608 ENSMICT00000053152.1 
Naked Mole Rat Heterocephalus glaber 10181 GEBF01006011.1 
Olive Baboon Papio anubis 9555 ENSPANT00000018547.1 
Opossum Monodelphis domestica 13616 ENSMODT00000035940.1 
Orangutan Pongo abelii 9601 ENSPPYT00000004019.2 
Panda Ailuropoda melanoleuca 9646 ENSAMET00000008032.1 
Pig Sus scrofa 9823 ENSSSCT00000026025.2 
Pika  Ochotona princeps 9978 ENSOPRT00000009673.1 
Platypus Ornithorhynchus anatinus 9258 ENSOANT00000032522.1 
Rabbit Oryctolagus cuniculus 9986 ENSOCUT00000026578.1 
Rainbow Trout Oncorhynchus mykiss 8022 AY593999 
Rat Rattus norvegicus 10116 ENSRNOT00000067085.3 
Sheep Ovis aries 9940 ENSOART00000019487.1 
Sloth Choloepus hoffmanni 9358 ENSCHOT00000001515.1 
Squirrel Ictidomys 
tridecemlineatus 
43179 ENSSTOT00000011393.1 
Turkey Meleagris gallopavo 9103 ENSMGAT00000011417.1 
African Green Monkey Chlorocebus sabaeus 60711 ENSCSAT00000003384.1 
Zebra Finch Taeniopygia guttata 59729 ENSTGUT00000005810.1 
Zebrafish Danio rerio 7955 ENSDART00000126737.3 
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Naked Mole Rat, which were obtained from NCBI’s Genbank.  The deduced sequence of Cavia porcellus CD59 527 
pseudogene is presented in this manuscript.   528 
Figure 1. 529 
 530 
  531 
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Figure 2. 532 
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I II III IV V
Human CD59 Exons
II III IV V
Guinea Pig CD59 
Pseudogene Exon-
Homologues
  
 
Exon 3 
   
        M  R  S  Q  D    V   T  L  L  R  L  L  L  I  L  A  M  F  S  C  A 
GP     atgagaagtcaagatg—-t-caccctactcaggctcctgctcatcctggccatgttctcttgtgca 
Human  atgggaatccaaggagggtctgtcctgttcgggctgctgctcgtcctggctgtcttctgccattca 
        M  G  I  Q  G  G  S  V  L  F  G  L  L  L  V  L  A  V  F  C  H  S 
        *        *  .        .  *  :     *  *  *  :  *  *  :  *        :   
  
 
Exon 4 
  
         
        G  C  R  L  L  R  F  Q  C  D  D  T  A  P  K  C  N  E  T  E  Y  C  T  
GP     ggttgcagactgttacgtttccaatgtgacgatacagctccaaaatgcaatgaaaccgaatactgcacc 
Human  ggtcatagcctgcagtgctacaactgtcctaacccaactgctgactgcaaaacagccgtcaattgttca 
        G  H  S  L  Q  C  Y  N  C  P  N  P  T  A  D  C  K  T  A  V  N  C  S    
        *        *        :  :  *     :  .  :  .  .  *  :     :        *  : 
         
        P  N  F  D  A  C  F  I  A  I  A  G 
GP     cctaactttgatgcatgcttcattgctatagctgg 
Human  tctgattttgatgcgtgtctcattaccaaagctgg 
        S  D  F  D  A  C  L  I  T  K  A  G 
           :  *  *  *  *  :  *  :     *  * 
 
 
Exon 5 
         T  R  Y  Y  R  H  C  -  R  R  D  D  C  N  L  D  F  V  L  Q  R  L  V 
GP     cacccgatactatcgccattgctagaggcgtgatgactgcaatctggactttgtcttgcaaagattaagt 
Human  gttacaagtgtataacaagtgttggaagtttgagcattgcaatttcaacgacgtcacaacccgcttgagg 
         L  Q  V  Y  N  K  C  W  K  F  E  H  C  N  F  N  D  V  T  T  R  L  R  
            :     *  .  :  *     :     :  .  *  *  :  :     *        *  * 
 
        E  N  N  T  V  F  K  C  C  W  A  D  M  G             T  A  G      V  
GP     gagaataacacggtgttcaaatgttgctgggcagacatggg-----------aacagccgg----tgtt 
Human  gaaaatgagctaacgtactactgctgcaagaaggacctgtgtaactttaacgaacagcttgaaaatggt 
        E  N  E  L  T  Y  Y  C  C  K  K  D  L  C  N  F  N  E  Q  L  E  N  G 
        *  *           :     *  *        *             
 
        V  T  I  S  P  G  K  T  V        L  L  V  P  V  L  T  A  V  W  N  L 
GP     gtaactatctcacccgggaagacagt------gctgctggtcccagttctgacagcagtctggaacctt 
Human  gggacatccttatcagagaaaacagttcttctgctggtgactccatttctggcagcagcctggagcctt 
        G  T  S  L  S  E  K  T  V  L  L  L  V  T  P  F  L  A  A  A  W  S  L  
                          *  *  *     *  *  *     *     *  :  *  .  *  .  * 
        V  F  - 
GP     gtcttctaa 
Human  catccctaa 
        H  P  -   
 
*   -identity 
:   -strongly similar 
.   -weakly similar  
Figure 3 
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                       M  R  S  Q  G  G  V  T  L  L  R  L  L  L  V  L  A  A  L  C 
Naked Mole-Rat        atgagaagtcagggaggtgtcaccctgctcaggctcctgctcgtcctggctgcgctgtgt 
Guinea Pig            atgagaagtca---agatgtcaccctactcaggctcctgctcatcctggccatgttctct 
                       M  R  S  Q     D  V  T  L  L  R  L  L  L  I  L  A  M  F  S 
                       *  *  *  *     .  *  *  *  *  *  *  *  *  :  *  *     :  .     
 
 
 
                       C  T  G  F  S  L  T  C  Y  E  C  A  S  H  N  Q  N  C  T  V 
Naked Mole-Rat        tgcacaggtttcagcctgacttgctatgagtgtgcttcccacaatcaaaactgcactgtt 
Guinea Pig            tgtgcaggttgcagactgttacgtttccaatgtgacgatacagctccaaaatgcaatgaa 
                       C  A  G  C  R  L  L  R  F  Q  C  D  D  T  A  P  K  C  N  E  
                       *  :  *        *        :  :  *     .           :  *  .  
 
 
                       P  I  V  C  A  P  D  I  D  A  C  L  Y  A  K  A  G  Q  R  V  
Naked Mole-Rat        cccatagtgtgtgcaccagatatcgatgcatgcctctatgctaaagctggccaacgagta 
Guinea Pig            accgaatactgcacccctaactttgatgcatgcttcattgctatagctacccga---tac 
                       T  E  Y  C  T  P  N  F  D  A  C  F  I  A  I  A  T     R  Y 
                       .        *  :  *  :  :  *  *  *  :     *              *   
 
 
                       Y  Q  Q  C  W  R  Y  A  D  C  N  S  Q  T  I  M  N  R  L  R 
Naked Mole-Rat        tatcaacaatgctggaggtatgctgactgcaactcgcaaactattatgaacagattacga 
Guinea Pig            tatcgccattgctagaggcgtgatgactgcaatctggactttgtcttgcaaagattaagt 
                       Y  R  H  C  -  R  R  D  D  C  N  L  D  F  V  L  Q  R  L  V 
                       *  :  :  *     *        *  *  *     :     :  :  :  *  *                                     
 
   
                       E  N  Q  V  L  Y  R  C  C  Q  K  D  L  C  N  T  G  L  Q  K 
Naked Mole-Rat        gagaaccaggtattatacagatgttgccagaaggatctgtgtaacacaggactccagaaa 
Guinea Pig            gagaataacacggtgttcaaatgttgctgggcagaca---------------tgggaaca 
                       E  N  N  T  V  F  K  C  C  W  A  D                 M  G  T 
                       *  *  :  .  :  :  :  *  *        *                                     
                       
 
 
                       D  D  G  T  A  P  L  S  G  K  T  M  L  L  V  T  P  F  L  A 
Naked Mole-Rat        gacgatggaacagctcccttatcagggaagacaatgctgctggtgaccccgtttctggcc 
Guinea Pig            gccggtgttgtaactatctcacccgggaagacagtgctgctggtc---ccagttctgaca  
                       A  G  V  V  T  I  S  P  G  K  T  V  L  L  V     P  V  L  T  
                                .              *  *  *     *  *  *     *     * 
 
 
                       A  V  W  N  L  C  F  -   
Naked Mole-Rat        gcagtctggaatctttgcttctaa 
Guinea Pig            gcagtctggaaccttgtcttctaa 
                       A  V  W  N  L  V  F  -  
                       *  *  *  *  *     * 
 
*   -identity 
:   -strongly similar 
.   -weakly similar 
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